Sort
82,697 grants matching “vaccine development”
Institutional Career Development Core
$1,915,096Edgar Raymond Miller · Johns Hopkins University · KL2 · FY2019 · TR
Live attenuated vaccines for epidemic and pandemic flu
$1,914,536Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U01 · FY2009 · AI
A single-dose prophylactic Japanese Encephalitis vaccine
$1,914,095Intercell Ag · U01 · FY2005 · AI
Functional B-cell Epitope Discovery for Arthropod-Borne Diseases
$1,914,095Washington University · N01 · FY2025 · AI
NIAID Centers of Excellence for Influenza Research and Response
$1,913,874Anice Lowen · Emory University · N01 · FY2024 · AI
Noroviruses and Epidemic Gastroenteritis
$1,913,459Kim Y. Green · Niaid Extramural Activities · Z01 · FY2007 · AI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$1,913,010Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2023 · FD
Operations and Management
$1,912,696Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2017 · AI
NIAID Preclinical Development Support: Essential Core Activities
$1,912,456Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2021 · AI
HIV VACCINES TRIAL UNITS
$1,912,186Fred Hutchinson Cancer Research Center · U01 · FY2004 · AI
COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2
$1,912,140Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry
$1,911,904Irwin M Chaiken · Drexel University · P01 · FY2019 · AI
Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWAL
$1,909,600Rainer Lohmann · University Of Rhode Island · P42 · FY2022 · ES
Establishment and Expansion of SPF Rhesus Colony
$1,908,805Rudolf P Bohm · Tulane University Of Louisiana · U24 · FY2008 · RR
Natural History of HPV Infection in Men: The HIM Study
$1,908,772Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Case Clinical Trials Unit
$1,908,328Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2015 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$1,907,967Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Developing Vaccine Candidates for the SARS Coronavirus
$1,907,553Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2009 · AI
Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry
$1,907,518Irwin M Chaiken · Drexel University · P01 · FY2020 · AI
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$1,907,385Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mosquito Immune Responses and Malaria Transmission
$1,907,206Carolina Barillas-Mury · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Fast-Track Production of a Heptavalent Botulinum Vaccine
$1,907,093Dynport Vaccine Company, Llc · U01 · FY2003 · AI
Project 4:Targeting M2-like Macrophages and MDSC with Myelolytic-Virotherapy
$1,907,013Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment
$1,906,882Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2017 · AI
Center for Research on Processes in Evolution
$1,906,576Larry J Forney · University Of Idaho · P20 · FY2010 · RR